Fresenius SE Raises 2012 Outlook After Strong First Quarter
04/26/2012| 03:46am US/Eastern
German healthcare company Fresenius SE & Co. KGaA (>> Fresenius SE & Co KGaA) on Thursday raised its 2012 based on strong figures in the first quarter.
-First-quarter sales increased by 13% (10% in constant currency) to EUR4.42 billion (Q1 2011: EUR3.92 billion).
-Group EBIT rose by 15% (12% in constant currency) to EUR661 million (Q1 2011: EUR575 million).
-Group net income grew by 18% (15% in constant currency) to EUR200 million (Q1 2011: EUR170 million). Including an investment gain at Fresenius Medical Care, net income increased to EUR230 million.
-Based on the financial results in the first quarter, Fresenius raises its guidance. For 2012, Fresenius now expects net income growth of 12% to 15% in constant currency. Previously, the company expected net income growth of 8% to 11%.
-Sales growth of 10% to 13% in constant currency is now projected at the upper end of the targeted range.
-The final figures for the first quarter of 2012 will be provided on May 3, 2012, as originally scheduled.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Order free Annual Report for Fresenius Medical Care AG & Co. KGaA
Visit http://djnweurope.ar.wilink.com/?ticker=DE0005785802 or call +44 (0)208 391 6028